SEC 13F Intelligence

Nordea Investment Management AB / PFE

Nordea Investment Management AB’s Pfizer Inc Position

Does Nordea Investment Management AB own Pfizer Inc (PFE)? Yes — 4.78M shares worth $133M (+0.12% of its 13F portfolio) as of Q1 2026, down from 4.82M shares the prior filed quarter.

Position Value
$133M
Q1 2026
Shares
4.78M
% of Portfolio
+0.12%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $2.2BQ4 ’18Q1 ’19: $700MQ2 ’19: $681MQ3 ’19: $556MQ4 ’19: $582MQ4 ’19Q1 ’20: $436MQ2 ’20: $719MQ3 ’20: $406MQ4 ’20: $404MQ4 ’20Q1 ’21: $414MQ2 ’21: $445MQ3 ’21: $496MQ4 ’21: $775MQ4 ’21Q1 ’22: $673MQ2 ’22: $626MQ3 ’22: $498MQ4 ’22: $422MQ4 ’22Q1 ’23: $335MQ2 ’23: $304MQ3 ’23: $262MQ4 ’23: $235MQ4 ’23Q1 ’24: $120MQ2 ’24: $99MQ3 ’24: $87MQ4 ’24: $108MQ4 ’24Q1 ’25: $98MQ2 ’25: $144MQ3 ’25: $148MQ4 ’25: $120MQ4 ’25Q1 ’26: $133Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.78M$133M+0.12%
Q4 20254.82M$120M+0.10%
Q3 20256.10M$148M+0.13%
Q2 20255.93M$144M+0.13%
Q1 20253.90M$98M+0.10%
Q4 20244.07M$108M+0.11%
Q3 20242.99M$87M+0.10%
Q2 20243.53M$99M+0.12%
Q1 20244.30M$120M+0.14%
Q4 20238.21M$235M+0.30%
Q3 20237.95M$262M+0.36%
Q2 20238.36M$304M+0.42%
Q1 20238.28M$335M+0.49%
Q4 20228.27M$422M+0.66%
Q3 202211.21M$498M+0.81%
Q2 202212.20M$626M+0.93%
Q1 202212.80M$673M+0.85%
Q4 202113.06M$775M+0.93%
Q3 202111.33M$496M+0.65%
Q2 202111.37M$445M+0.60%
Q1 202111.47M$414M+0.60%
Q4 202010.96M$404M+0.65%
Q3 202011.17M$406M+0.76%
Q2 202022.27M$719M+0.75%
Q1 202013.47M$436M+1.05%
Q4 201914.97M$582M+1.16%
Q3 201915.35M$556M+1.21%
Q2 201915.72M$681M+1.52%
Q1 201916.47M$700M+1.46%
Q4 201850.41M$2.2B+1.83%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nordea Investment Management AB’s full portfolio or all institutional holders of PFE.